These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25358084)

  • 21. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides.
    Baranauskienė L; Hilvo M; Matulienė J; Golovenko D; Manakova E; Dudutienė V; Michailovienė V; Torresan J; Jachno J; Parkkila S; Maresca A; Supuran CT; Gražulis S; Matulis D
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):863-70. PubMed ID: 20166809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.
    Genis C; Sippel KH; Case N; Cao W; Avvaru BS; Tartaglia LJ; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Rosser CJ; McKenna R
    Biochemistry; 2009 Feb; 48(6):1322-31. PubMed ID: 19170619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
    Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies.
    Bozdag M; Ferraroni M; Nuti E; Vullo D; Rossello A; Carta F; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2014 Jan; 22(1):334-40. PubMed ID: 24300919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
    D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
    J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.
    Vaškevičienė I; Paketurytė V; Pajanok N; Žukauskas Š; Sapijanskaitė B; Kantminienė K; Mickevičius V; Zubrienė A; Matulis D
    Bioorg Med Chem; 2019 Jan; 27(2):322-337. PubMed ID: 30553625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases.
    Čapkauskaitė E; Zubrienė A; Paketurytė V; Timm DD; Tumkevičius S; Matulis D
    Bioorg Chem; 2018 Apr; 77():534-541. PubMed ID: 29459130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.
    Lau J; Pan J; Zhang Z; Hundal-Jabal N; Liu Z; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3064-8. PubMed ID: 24878197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.
    Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
    Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
    Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Wang ZC; Qin YJ; Wang PF; Yang YA; Wen Q; Zhang X; Qiu HY; Duan YT; Wang YT; Sang YL; Zhu HL
    Eur J Med Chem; 2013 Aug; 66():1-11. PubMed ID: 23777898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.
    Pacchiano F; Aggarwal M; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Chem Commun (Camb); 2010 Nov; 46(44):8371-3. PubMed ID: 20922253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.